Renal Function, Peak Anti‐Xa Levels and Enoxaparin Dosing

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 1, 2004-03 ,pp. : 14-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Anti-Xa Activity After a Single Intravenous Bolus of Low-dose Enoxaparin in Patients With and Without End-stage Renal Disease

By Lin J-S   Wang W-J   Lin W-C   Wu X-M   Chao C-L  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1890-1896

Field House Publishing

Access to resources Recommend Favorite

Plasma Anti-Xa Monitoring for Low-Molecular-Weight Heparins in Patients with Chronic Kidney Disease

By Gallieni Maurizio  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 773-774

Adis International

Access to resources Recommend Favorite

Clopidogrel/enoxaparin sodium: Retroperitoneal haematoma successfully treated with eptacog-α in an elderly patient with renal failure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1152, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Factors Associated with Bleeding in Elderly Hospitalized Patients Treated with Enoxaparin Sodium: A Prospective, Open-Label, Observational Study

By Levin Avi  

Drugs & Aging, Vol. 26, Iss. 1, 2009-01 ,pp. : 77-85

Adis International

Access to resources Recommend Favorite